Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous melanoma (mCM) patients, but their efficacy in young adults aged less than 40 years remains unclear.Materials and methodsWe retrospectively analyzed 303 stage IV melanoma patients of different ages treate...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
23 January 2023
|
| In: |
Frontiers in medicine
Year: 2023, Jahrgang: 10, Pages: 1-7 |
| ISSN: | 2296-858X |
| DOI: | 10.3389/fmed.2023.1117816 |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2023.1117816 Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fmed.2023.1117816 |
| Verfasserangaben: | Devayani Machiraju, Sarah Schäfer, Philip Beckhove, Jasmin Roth, Carsten Schulz and Jessica C. Hassel |
Search Result 1